Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ALTRESYN - Health Canada Drug Approval Details

Approvals/Health Canada/ALTRESYN

Authorized

STANDARD

ALTRESYN

CEVA ANIMAL HEALTH INC🇨🇦 Health Canada

Approval Date: Feb 6, 2026
Approval ID: a4d733e1cf6fdad5
Company: CEVA ANIMAL HEALTH INC
Type: Standard

Approval Details

Approval Id: a4d733e1cf6fdad5
Drug Approval Canada Name: ALTRESYN
Product Name: ALTRESYN
Status: Dormant
Status Date: 2024-06-27
Original Market Date: 2017-04-25
Drug Class: Veterinary
Dosage Form: Solution
Route Of Administration: Oral
Schedule: Prescription
Atc Original: Not Applicable
Aig Number: 0116940001
Company Name: CEVA ANIMAL HEALTH INC
Company Address: 150 Research Park, Suite 225 Guelph Ontario Canada N1G 4T2

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 6, 2026

Approval ID

a4d733e1cf6fdad5

Type

Standard

Back to Health Canada Approvals